LAWSUITS NEWS & LEGAL INFORMATION
Medifast Weight Loss Programs and Products False Advertising Settlement
New York, NY: A $3.7 million settlement has been agreed between Jason Pharmaceuticals, a subsidiary of Medifast Inc, and the Federal Trade Commission (FTC), resolving charges that the company made unsupported claims about its weight loss programs and products.
Medifast-brand low-calories meal substitutes, including its most popular plan called the Medifast "5 and 1"plan that consists of 800-1,000 calories per day, are sold by Jason Pharmaceuticals. The FTC alleges the company made false and misleading claims about the success people have had with the programs, in achieving or maintaining weight loss or weight control. These claims were in direct violation of a ban imposed on the company in 1992, by the FTC. Each day the company violated the ban, it could be fined up to $16,000.
In their case, United States of America (for the Federal Trade Commission), Plaintiff, v. Jason Pharmaceuticals, Inc., Defendant (United States District Court for the District of Columbia), Case No. 1:12-cv-01476, FTC Docket No. C-3392, the FTC claims Jason Pharmaceuticals made unsupported representations since at least November 2009. These claims implied or stated that using Medifast programs and products would allow consumers to lose 2-5 pounds per week. The company also represented that the experiences of consumer endorsers featured in the advertisements were typical, and that consumers would lose more than 30 pounds, according to the complaint.
Published on Nov-20-12
Medifast-brand low-calories meal substitutes, including its most popular plan called the Medifast "5 and 1"plan that consists of 800-1,000 calories per day, are sold by Jason Pharmaceuticals. The FTC alleges the company made false and misleading claims about the success people have had with the programs, in achieving or maintaining weight loss or weight control. These claims were in direct violation of a ban imposed on the company in 1992, by the FTC. Each day the company violated the ban, it could be fined up to $16,000.
In their case, United States of America (for the Federal Trade Commission), Plaintiff, v. Jason Pharmaceuticals, Inc., Defendant (United States District Court for the District of Columbia), Case No. 1:12-cv-01476, FTC Docket No. C-3392, the FTC claims Jason Pharmaceuticals made unsupported representations since at least November 2009. These claims implied or stated that using Medifast programs and products would allow consumers to lose 2-5 pounds per week. The company also represented that the experiences of consumer endorsers featured in the advertisements were typical, and that consumers would lose more than 30 pounds, according to the complaint.
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.Published on Nov-20-12
